Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03821701
Recruitment Status : Recruiting
First Posted : January 30, 2019
Last Update Posted : August 7, 2019
Sponsor:
Collaborators:
Baoji Central Hospital
First Affiliated Hospital Xi'an Medical University
Information provided by (Responsible Party):
First Affiliated Hospital Xi'an Jiaotong University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 31, 2021
Estimated Study Completion Date : January 31, 2022